158 related articles for article (PubMed ID: 11592360)
1. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
Isaacs JD; Greer S; Sharma S; Symmons D; Smith M; Johnston J; Waldmann H; Hale G; Hazleman BL
Arthritis Rheum; 2001 Sep; 44(9):1998-2008. PubMed ID: 11592360
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
Lorenzi AR; Clarke AM; Wooldridge T; Waldmann H; Hale G; Symmons D; Hazleman BL; Isaacs JD
Arthritis Rheum; 2008 Feb; 58(2):370-5. PubMed ID: 18240243
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.
Ponchel F; Verburg RJ; Bingham SJ; Brown AK; Moore J; Protheroe A; Short K; Lawson CA; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma D; van Laar JM; Papadaki HA; Emery P; Isaacs JD
Arthritis Res Ther; 2005; 7(1):R80-92. PubMed ID: 15642146
[TBL] [Abstract][Full Text] [Related]
4. Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.
Anderson AE; Lorenzi AR; Pratt A; Wooldridge T; Diboll J; Hilkens CM; Isaacs JD
Rheumatology (Oxford); 2012 Aug; 51(8):1397-406. PubMed ID: 22447884
[TBL] [Abstract][Full Text] [Related]
5. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H).
Walsh M; Chaudhry A; Jayne D
Ann Rheum Dis; 2008 Sep; 67(9):1322-7. PubMed ID: 18055469
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
[TBL] [Abstract][Full Text] [Related]
9. Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.
Lockwood CM; Hale G; Waldman H; Jayne DR
Rheumatology (Oxford); 2003 Dec; 42(12):1539-44. PubMed ID: 12949252
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
11. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival.
Uhrin Z; Wang BW; Matsuda Y; Strober S; Genovese MC
Arthritis Rheum; 2001 Jul; 44(7):1525-8. PubMed ID: 11465702
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia.
Lundin J; Porwit-MacDonald A; Rossmann ED; Karlsson C; Edman P; Rezvany MR; Kimby E; Osterborg A; Mellstedt H
Leukemia; 2004 Mar; 18(3):484-90. PubMed ID: 14749699
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
Leandro MJ; Cambridge G; Ehrenstein MR; Edwards JC
Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
[TBL] [Abstract][Full Text] [Related]
16. CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.
Isaacs JD; Manna VK; Rapson N; Bulpitt KJ; Hazleman BL; Matteson EL; St Clair EW; Schnitzer TJ; Johnston JM
Br J Rheumatol; 1996 Mar; 35(3):231-40. PubMed ID: 8620297
[TBL] [Abstract][Full Text] [Related]
17. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes.
Bazzani C; Filippini M; Caporali R; Bobbio-Pallavicini F; Favalli EG; Marchesoni A; Atzeni F; Sarzi-Puttini P; Gorla R
Autoimmun Rev; 2009 Jan; 8(3):260-5. PubMed ID: 19027090
[TBL] [Abstract][Full Text] [Related]
19. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
